Standard Biotools (LAB) FCF Margin (2010 - 2026)
Standard Biotools (LAB) reported FCF Margin of 221.87% for Q1 2026, down 4712.0% year-over-year from 4.81% in Q1 2025, and down 1012.43% on a QoQ basis from 24.32% in Q4 2025.
Standard Biotools (LAB) has 17 years of FCF Margin data on file, last reported at 221.87% in Q1 2026.
- Quarterly FCF Margin fell 4712.0% year-over-year to 221.87% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 100.6% (up 3040.0% YoY) and the FY2025 annual result came in at 88.12%, up 7150.0% from the prior year.
- FCF Margin declined to 221.87% in Q1 2026 per LAB's latest filing, from 24.32% in the prior quarter.
- Across five years, FCF Margin topped out at 24.32% in Q4 2025 and bottomed at 221.87% in Q1 2026.
- The 5-year median for FCF Margin is 100.89% (2022), against an average of 97.54%.
- The widest annual swing landed in 2023, when FCF Margin jumped 12795 bps; it then plunged 14548 bps in 2024.
- Tracing LAB's FCF Margin over 5 years: stood at 73.78% in 2022, then soared by 46 bps to 40.12% in 2023, then sank by 50 bps to 60.29% in 2024, then surged by 140 bps to 24.32% in 2025, then slumped by 1012 bps to 221.87% in 2026.
- Per Business Quant, the three latest LAB FCF Margin figures stand at 221.87% (Q1 2026), 24.32% (Q4 2025), and 118.09% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | -221.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -221.87% |
| Dec 31, 2025 | 24.32% |
| Sep 30, 2025 | -118.09% |
| Jun 30, 2025 | -103.64% |
| Mar 31, 2025 | -174.75% |
| Dec 31, 2024 | -60.29% |
| Sep 30, 2024 | -118.11% |
| Jun 30, 2024 | -182.23% |
| Mar 31, 2024 | -138.90% |
| Dec 31, 2023 | -40.12% |
| Sep 30, 2023 | -48.56% |
| Jun 30, 2023 | -36.75% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -73.78% |
| Sep 30, 2022 | -100.89% |
| Jun 30, 2022 | -164.70% |
| Mar 31, 2022 | -62.10% |
| Sep 30, 2021 | -174.92% |
| Jun 30, 2021 | -124.64% |
| Mar 31, 2021 | -60.45% |
| Dec 31, 2020 | -32.37% |
| Sep 30, 2020 | -12.39% |
| Jun 30, 2020 | -13.17% |
| Mar 31, 2020 | -171.77% |
| Dec 31, 2019 | -18.55% |
| Sep 30, 2019 | -22.24% |
| Jun 30, 2019 | -19.27% |
| Mar 31, 2019 | -67.74% |
| Dec 31, 2018 | -2.04% |
| Sep 30, 2018 | -14.72% |
| Jun 30, 2018 | -16.65% |
| Mar 31, 2018 | -64.37% |
| Dec 31, 2017 | 1.74% |
| Sep 30, 2017 | -34.49% |
| Jun 30, 2017 | -35.26% |
| Mar 31, 2017 | -35.95% |
| Dec 31, 2016 | -45.54% |
| Sep 30, 2016 | -67.46% |
| Jun 30, 2016 | -31.50% |
| Mar 31, 2016 | -30.81% |
| Dec 31, 2015 | -19.01% |
| Sep 30, 2015 | -45.16% |
| Jun 30, 2015 | -32.25% |
| Mar 31, 2015 | -40.07% |
| Dec 31, 2014 | -14.96% |
| Sep 30, 2014 | -34.48% |
| Jun 30, 2014 | -8.83% |
| Mar 31, 2014 | -48.05% |
| Dec 31, 2013 | 6.50% |
| Sep 30, 2013 | -10.72% |
| Jun 30, 2013 | -16.31% |
| Mar 31, 2013 | -10.88% |
| Dec 31, 2012 | -27.22% |
| Sep 30, 2012 | -29.09% |
| Jun 30, 2012 | -37.40% |
| Mar 31, 2012 | -64.32% |
| Dec 31, 2011 | -22.58% |
| Sep 30, 2011 | -25.12% |
| Jun 30, 2011 | -115.10% |
| Mar 31, 2011 | -16.66% |
| Dec 31, 2010 | -27.87% |
| Sep 30, 2010 | -887.50% |